SP442FK506 ATTENUATES PROTEINURIA BY INHIBITING WNT/β-CATENIN MEDIATED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN RATS WITH DIABETIC NEPHROPATHY. (13th June 2019)